ABC | Volume 112, Nº2, February 2019

Original Article Dippe Jr. et al Study of myocardial perfusion in obese individuals without known IHD Arq Bras Cardiol. 2019; 112(2):121-128 1. WorldHealthOrganization (WHO). Obesity: preventing andmanaging the global epidemic. Report of a WHO Consultation. Geneva; 2000. (WHO Obesity Technical Report Series; 284). 2. WorldHealthOrganization.(WHO).10factsonobesity.2017.[citado2018out 30]. Disponível em: http://www.who.int/mediacentre/factsheets/fs311/en/. 3. Sociedade Brasileira de Endocrinologia e Metabologia. (SBEM). 2017. [citado 2018 out 30] Disponível em: http://www.endocrino.org.br/media/ uploads/PDFs/vigitel.pdf. 4. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation . 2006;113(6):898-918. 5. Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep. 2002;4(6):448-53. 6. EmergingRiskFactorsCollaboration,WormserD,KaptogeS,DiAngelantonio E, Wood AM, Pennells L, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085-95. 7. Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol . 1977;39(3):452-8. 8. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med . 1990;322(13):882-9. 9. Wilson PW, D’Agostino RB, Sullivan L, PariseH, KannelWB. Overweight and obesity as determinants of cardiovascular risk: the Framinghamexperience. Arch Intern Med . 2002;162(16):1867-72. 10. Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR, et al. Noninvasive evaluation of ischemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J. 2003;24(9):789-800. 11. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Biagini E, et al. Prognostic stratification of obese patients by 99mTc-tetrofosminmyocardial perfusion imaging. J Nucl Med. 2006;47(8):1302-6. 12. Xingping K, Shaw LJ, Hayes SW, Hachamovitch R, Abidov A, Cohen I. et al. Impact of body mass index on cardiac mortality in patients with know or suspect coronary artery disease undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol . 2006:47(7):1418-26. 13. Korbee, RS, Boiten HJ, Ottenhof M, Valkema R, van Domburg RT, Schinkel AF.What is the value of 99mTc-tetrofosminmyocardial perfusion imaging for the assessment of very long-termoutcome in obese patients? J Nucl Cardiol. 2013;20(2):227-33. 14. Hirko KA, Kantor ED, Cohen SS, Blot WJ, Stampfer MJ, Signorello LB. Body mass index in young adulthood, obesity trajectory, and prematuremortality. Am J Epidemiol . 2015;182(5):441-50. 15. International Diabetes Federation (IDF). IDF Diabetes Atlas. 8th ed. 2017. [citado 2018 out 30]. Disponível em: http://www.diabetesatlas.org/. 16. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547-55. 17. HermanWH,ZimmetP.Type2diabetes:anepidemicglobalrequiringglobal attention and urgent action. Diabetes Care. 2012;35(5):943-4. 18. Shaw LJ, Butler J. Targeting priority populations to reduce disparities in cardiovascular care: health equity for all. J Am Coll Cardiol. 2014;64(4):346-8. 19. DaviglusML, TalaveraGA, Avilés-SantaML, AllisonM, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the Unites States. JAMA. 2012;308(17):1775-84. 20. HenzlovaMJ, Duvall WL, Einstein AJ, TravinMI, VerberneHJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;23(3):606-39. 21. Zaret B, Beller G. Clinical nuclear cardiology: state of the art and future directions. 4th ed. Philadelphia: Mosby; 2010. 22. Gualandro DM, Yu PC, Caramelli B, Marques AC, Calderaro D, Fornari LS, et al.,Sociedade Brasileira de Cardiologia. 3ª Diretriz de avaliação cardiovascular perioperatória da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2017;109(3 Suppl 1):1-104. 23. Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR, et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J. 2003;24(9):789-800. 24. Lim SP, Arasaratnam P, Chow BJ, Beanlands RS, Hessian RC. Obesity and the challenges of noninvasive imaging for the detection of coronary artery disease. Can J Cardiol. 2015:31(2):223-6. 25. Duvall WL, Croft LB, Corriel JS, Einstein AJ, Fisher JE, Haynes PS, et al. SPECT myocardial perfusion imaging in morbidly obese patients: image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value. J Nucl Cardiol. 2006;13(2):202-9. 26. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the cardiac imaging committee, council on clinical cardiology, and the cardiovascular imaging and intervention committee, council on cardiovascular radiology and intervention, American Heart Association. Circulation. 2005;111(5):682-96. 27. Cerci MS, Cerci JJ, Cerci RJ, Pereira Neto CC, Trindade E, Delbeke D, et al. Myocardial perfusion imaging is a strong predictor of death inwomen. JACC Cardiovasc Imaging. 2011;4(8):880-8. 28. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM2009 appropriate use criteria for cardiac radionuclide imaging: a report of the american college of cardiology foundation appropriate use criteria task force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009 ; 53(23):2201-29. 29. Fiechter M, Gebhard C, Fuchs TA, Ghadri JR, Stehli J, Kazakauskaite E, et al. Cadmium-zinc-telluride myocardial perfusion imaging in obese patients. J Nucl Med . 2012;53(9):1401-6. 30. Berman DS, Kang X, Nishina H, Slomka PJ, Shaw LJ, Hayes SW, et al. Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients. J Nucl Cardiol . 2006;13(2):191-201. 31. Aggarwal NR, Drozdova A, Askew JW 3rd, Kemp BJ, Chareonthaitawee P. Feasibility and diagnostic accuracy of exercise treadmill nitrogen-13 ammonia PET myocardial perfusion imaging of obese patients. J Nucl Cardiol. 2015;22(6):1273-80. 32. Chow BJ, Dorbala S, Di Carli MF, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of PET myocardial perfusion imaging in obese patients. JACC Cardiovasc Imaging. 2014;7(3):278-87. References 127